The safety of phosphate binders.

about

Effect of chitosan chewing gum on reducing serum phosphorus in hemodialysis patients: a multi-center, randomized, double-blind, placebo-controlled trial.Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

P2860

Q33841652-9E251BC1-CE1C-443E-A028-A6EE0D4A9249 Q37052751-A1C4E334-BA4C-42DD-A4A9-FBC100AEF9C2

P2860

The safety of phosphate binders.

Item

http://www.wikidata.org/entity/Q36565049

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

The safety of phosphate binders.

@ast

The safety of phosphate binders.

@en

type

Item

label

The safety of phosphate binders.

@ast

The safety of phosphate binders.

@en

prefLabel

The safety of phosphate binders.

@ast

The safety of phosphate binders.

@en

P1476

The safety of phosphate binders

@en

P2093

Maria Pau Valenzuela

http://www.w3.org/2001/XMLSchema#string

P2860

The evolving role of statins in the management of atherosclerosis.

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

Does calcium kill ESRD patients--the skeptic's perspective.

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD).

Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications.

The impact of calcimimetic agents on the use of different classes of phosphate binders: results of recent clinical trials.

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States.

The role of daily dialysis in the control of hyperphosphatemia.

P304

675-686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.5.5.675

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jaume Almirall

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16907657

http://www.w3.org/2001/XMLSchema#string

The safety of phosphate binders.

about

P2860

P2860

The safety of phosphate binders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698